HALO
Halozyme Therapeutics Inc
$63.08
-2.19% ($1.41)
Volume
1.54M
52W High
$82.22
52W Low
$47.50
Market Cap
$9.34B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.55
Whisper EPS
$1.49
3.7% below consensus
Last Quarter
-$0.24
Current Streak
1 Miss
Avg Surprise (4Q)
-52.90%
Next Earnings Report
Reports in 28 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Feb 24, 2026
1-Day:
-0.01%
Q4 2025
Feb 17, 2026
1-Day:
-9.01%
Q3 2025
Oct 28, 2025
1-Day:
-0.21%
Q2 2025
Aug 5, 2025
1-Day:
+2.48%
Revenue & Financial Performance
Revenue Whisper
$397.0M
TWN Proprietary Estimate
Last Quarter Revenue
$451.8M
+51.6% YoY
Gross Margin
77.4%
Net Margin: -31.3%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $451.8M | +51.6% | 77.4% | 56.3% | -$141.6M |
| Q3'25 | $354.3M | +22.1% | 84.4% | 61.5% | $175.2M |
| Q2'25 | $325.7M | +40.8% | 85.8% | 62.2% | $165.2M |
| Q1'25 | $264.9M | +35.2% | 81.7% | 53.4% | $118.1M |
| Q4'24 | $298.0M | +29.6% | 85.9% | 58.9% | $137.0M |
| Q3'24 | $290.1M | +34.3% | 83.0% | 56.3% | $137.0M |
| Q2'24 | $231.4M | +4.7% | 75.2% | 50.7% | $93.2M |
| Q1'24 | $195.9M | +20.8% | 76.5% | 48.8% | $76.8M |
Company Information
Symbol
HALO
Company
Halozyme Therapeutics Inc
Market Cap
$9.34B
Next Earnings
May 5, 2026